Hiponatremia: abordagem clínica e terapêutica

Autores

  • Fernando Abreu Serviço de Nefrologia do Hospital de Santa Maria, Lisboa
  • Francisco Teixeira de Sousa Serviço de Nefrologia do Hospital de Santa Maria, Lisboa
  • M. Martins Prata Serviço de Nefrologia do Hospital de Santa Maria, Lisboa

Palavras-chave:

antagonistas dos receptores da hormona anti-diurética, cirrose hepática, hiponatremia, hipovolemia, insuficiência cardíaca congestiva, polidipsia, síndroma de secreção inapropriada de hormona anti-diurética

Resumo

A hiponatremia é a alteração electrolítica mais
frequente na prática clínica hospitalar e reflecte uma
alteração do balanço de água, com consequente
diminuição da osmolalidade plasmática. Pode ter
várias causas que incluem: perda de fluidos, estados
edematosos, nomeadamente insuficiência cardíaca
congestiva, cirrose hepática e síndroma nefrótica,
síndroma de secreção inapropriada de hormona anti-diurética (SIADH), polidipsia primária e patologias
do foro endocrinológico. Na maioria dos casos, a
conjugação de parâmetros clínicos e analíticos
incluindo determinação das osmolalidades,
plasmática e urinária, concentração urinária de sódio
e avaliação clínica do compartimento extra-celular,
permite chegar ao diagnóstico causal. O tratamento
da hiponatremia assenta na terapêutica etiológica e
na correcção da concentração sérica de sódio,
mediante regras fundamentais e após ponderar de
forma individualizada o balanço entre os riscos
inerentes da própria hiponatremia e os da sua rápida
correcção, em particular da desmielinização
osmótica das células cerebrais. Os antagonistas dos
receptores da hormona anti-diurética, ou
aquaréticos, abrem novas perspectivas na
terapêutica da hiponatremia associada às situações
de insuficiência cardíaca, cirrose hepática e SIADH.
Neste artigo, pretendeu-se efectuar uma
abordagem essencialmente clínica desta perturbação
do equilíbrio hidro-electrolítico, sem descurar os
aspectos relacionados com a sua etiopatogénese, e
dando particular ênfase ao diagnóstico etiológico
diferencial e à respectiva terapêutica.

Downloads

Não há dados estatísticos.

Referências

Anderson RJ. Hospital-associated hyponatremia. Kidney Int 1986; 29: 1237-1247.

Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984; 12: 975-977.

Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 819-829.

Rose BD. Hypoosmolal states-Hyponatremia. In: Rose BD, ed. Clinical physiology of acid-base and electrolyte disorders. New

York: McGraw-Hill 1994: 651-694.

Rose BD. Introduction to disorders of osmolality. In: Rose BD, ed. Clinical physiology of acid-base and electrolyte disorders. New

York: McGraw-Hill 1994: 638-650.

Hariprasad MK, Eisinger RP, Nadler IM, Padmanabhan CS, Nidus BD. Hyponatremia in psychogenic polydipsia. Arch Intern Med

; 140: 1639-1642.

Verbalis JG. Adaptation to acute and chronic hyponatremia: implications for symptomatology, diagnosis and therapy. Sem

Nephrol 1998; 18: 3-19.

Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest

; 103: 601-606.

Szatalowicz VL, Miller PD, Lacher JW et al. Comparative effect of diuretics on renal water excretion in hyponatremic oedematous

disorders. Clin Sci 1982; 62: 235-238.

Gross P, Hensen J. Evaluation of hyponatremia: is there a rational approach? Nephrol Dial Transplant 1995; 10:1789-1791.

Bressler RB, Huston DP. Water intoxication following moderatedose intravenous cyclophosphamide. Arch Intern Med 1985; 145:

-549.

Ten Holt WL, Van Iperen CE, Schrijver, Barttelink AK. Severe hyponatremia during therapy with fluoxetine. Arch Intern Med

; 156: 681-682.

Tang WW, Kaptein EM, Feinstein EI, Massry SG. Hyponatremia in hospitalised patients with the acquired immunodeficiency

syndrome (AIDS) and the AIDS-related complex. Am J Med 1993;94: 169-174.

Glassock RJ, Cohen AH, Danovitch G, Parsa KP. Human immunodeficiency virus infection and the kidney. Ann Intern

Med 1990; 112: 35-49.

Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polyuria and

hyponatremia. N Engl J Med 318: 397-403.

Hilden T, Svendsen TL. Electrolyte disturbances in beer drinkers. Lancet 1975; 2: 245-246.

Thaler SM, Teitelbaum I, Berl T. “Beer potomania” in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis

; 31: 1028-1031.

Halperin ML, Oh MS. The Dysnatremias: Hyponatremia and Hypernatremia. In: Glassock RJ, ed. Current Therapy in Nephrology

and Hypertension, 4th ed, St. Louis, Mosby, 1998: 1-7.

Stuart CA, Neelon FA, Lebovitz HE. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Engl J Med 1980; 303:

-1082.

Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats.

Brain Res 1991; 567: 274-282.

Videen JS, Michaelis T, Pinto P, Ross BD. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic

resonance spectroscopy study. J Clin Invest 1995; 95: 788-793.

Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia.

Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991; 88: 303-309.

Adrogué JA, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581-1589.

Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 1992;

: 891-897.

Brenner BM, Coe F, Rector F. Renal Physiology in Health and Disease. 1st ed, Philadelphia, WB Saunders 1987: 73-81.

Hillier TA, Abbott RD, Barret EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999; 106: 399-403

Marino PL. Hypertonic and hypotonic syndromes. In Marino PL, ed. The ICU Book. 2nd ed, Pennsylvania, Williams & Wilkins

: 641-645.

Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia.

Kidney Int 1989; 35: 69-75

Laureano R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med 1997; 126: 57-62.

Brunner JE, Redmond JM, Haggar AM, Kruger DF, Elias SB. Central pontine myelinolysis and pontine lesions after rapid correction

of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol 1990; 27: 61-66.

Vanguri P, Kolsky CL, Silverman B, Shin ML. Complement activation by isolated myelin: activation of the classical pathway

in the absence of myelin-specific antibodies. Proc Natl Acad Sci USA 1982; 79: 3290-3294.

Cheng JC, Zikos D, Skopicki HA, et al. Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic

hyponatremia: the effect of rapid correction. Am J Med 1990; 88; 561-566.

Ponce P. Hiponatrémia em Cuidados Intensivos. In: Simões J, Boquinhas JM, eds. Actualizações em Nefrologia, Permanyer

Portugal 1995: 1-12

Soupart A, Penninckx R, Stenuit A, Perier O, Decaux G. Treatment of chronic hyponatremia in rats by intravenous saline: comparison

of rate versus magnitude of correction. Kidney Int 1992; 41:1662-1667.

Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive

correction of chronic hyponatremia by serum sodium lowering. Kidney Int 1994; 45: 193-200.

Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.

J Am Soc Nephrol 1994; 4: 1522-1530.

Lohr JW. Osmotic demyelinination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med 1994;

: 408-413.

Rouse D, Dalmeida W, Williamson FC, Suki WN. Captopril inhibits the hydroosmotic effect of ADH in the cortical collecting tubule.

Kidney Int 1987; 32: 845-850

Forrest JN, Cox M, Hong C, Morrison G, Bia M, Singer I. Superiority of demeclocycline over lithium in the treatment of

chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978; 298: 173-177.

Decaux G, Brimioulle S, Genette F, Mockel J. Treatment of the inappropriate secretion of antidiuretic hormone by urea. Am J

Med 1980; 69: 99-106.

Palm C, Gross P. V2-vasopressin receptor antagonists-mechanism of effect and clinical implications in hyponatremia. Nephrol Dial

Transplant 1999; 14: 2559-2562

Ficheiros Adicionais

Publicado

30-03-2001

Como Citar

1.
Abreu F, Teixeira de Sousa F, Martins Prata M. Hiponatremia: abordagem clínica e terapêutica. RPMI [Internet]. 30 de Março de 2001 [citado 16 de Novembro de 2024];8(1):37-48. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/1895

Edição

Secção

Artigos de Revisão